Managò Stefano, Mirabelli Peppino, Napolitano Michela, Zito Gianluigi, De Luca Anna C
Institute of Protein Biochemistry, National Research Council of Italy, Naples, Italy.
IRCCS SDN Istituto di Ricerca Diagnostica e Nucleare, Naples, Italy.
J Biophotonics. 2018 May;11(5):e201700265. doi: 10.1002/jbio.201700265. Epub 2018 Jan 17.
The analysis of leukocytes of peripheral blood is a crucial step in hematologic exams commonly used for disease diagnosis and, typically, requires molecular labelling. In addition, only a detailed, laborious phenotypic analysis allows identifying the presence and stage of specific pathologies such as leukemia. Most of the biochemical information is lost in the routine blood tests. In the present study, we tackle 2 important issues of label-free biochemical identification and classification of leukocytes using Raman spectroscopy (RS). First, we demonstrate that leukocyte subpopulations of lymphocytes (B, T and NK cells), monocytes and granulocytes can be identified by the unsupervised statistical approach of principal component analysis and classified by linear discriminant analysis with approximately 99% of accuracy. Second, we apply the same procedure to identify and discriminate normal B cells and transformed MN60 lymphocyte leukemic cell lines. In addition, we demonstrate that RS can be efficiently used for monitoring the cell response to low-dose chemotherapy treatment, experimentally eliciting the sensitivity to a dose-dependent cell response, which is of fundamental importance to determine the efficacy of any treatment. These results largely expand established Raman-based research protocols for label-free analysis of white blood cells, leukemic cells and chemotherapy treatment follow-up.
外周血白细胞分析是血液学检查中的关键步骤,常用于疾病诊断,通常需要进行分子标记。此外,只有详细、繁琐的表型分析才能确定白血病等特定疾病的存在和阶段。大多数生化信息在常规血液检测中会丢失。在本研究中,我们利用拉曼光谱(RS)解决了白细胞无标记生化识别和分类的两个重要问题。首先,我们证明淋巴细胞(B细胞、T细胞和NK细胞)、单核细胞和粒细胞的白细胞亚群可以通过主成分分析的无监督统计方法进行识别,并通过线性判别分析进行分类,准确率约为99%。其次,我们应用相同的程序来识别和区分正常B细胞和转化的MN60淋巴细胞白血病细胞系。此外,我们证明RS可以有效地用于监测细胞对低剂量化疗治疗的反应,通过实验得出剂量依赖性细胞反应的敏感性,这对于确定任何治疗的疗效至关重要。这些结果极大地扩展了已建立的基于拉曼的研究方案,用于白细胞、白血病细胞的无标记分析和化疗治疗随访。